<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang D</submitter><funding>Shenzhen Science and Technology Innovation Program</funding><funding>National Natural Science Foundation of China</funding><pagination>29</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9628086</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>17(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Colorectal cancer (CRC) is one of the most common malignant neoplasms worldwide. Although marker genes associated with CRC have been identified previously, only a few have fulfilled the therapeutic demand. Therefore, based on differentially expressed genes (DEGs), this study aimed to establish a promising and valuable signature model to diagnose CRC and predict patient's prognosis.&lt;h4>Methods&lt;/h4>The key genes were screened from DEGs to establish a multiscale embedded gene co-expression network, protein-protein interaction network, and survival analysis. A support vector machine (SVM) diagnostic model was constructed by a supervised classification algorithm. Univariate Cox analysis was performed to construct two prognostic signatures for overall survival and disease-free</pubmed_abstract><journal>Biology direct</journal><pubmed_title>Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.</pubmed_title><pmcid>PMC9628086</pmcid><funding_grant_id>RCBS20210609103823044</funding_grant_id><funding_grant_id>82100586</funding_grant_id><pubmed_authors>Dai S</pubmed_authors><pubmed_authors>Liufu J</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Yang Q</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Xie B</pubmed_authors></additional><is_claimable>false</is_claimable><name>Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer.</name><description>&lt;h4>Background&lt;/h4>Colorectal cancer (CRC) is one of the most common malignant neoplasms worldwide. Although marker genes associated with CRC have been identified previously, only a few have fulfilled the therapeutic demand. Therefore, based on differentially expressed genes (DEGs), this study aimed to establish a promising and valuable signature model to diagnose CRC and predict patient's prognosis.&lt;h4>Methods&lt;/h4>The key genes were screened from DEGs to establish a multiscale embedded gene co-expression network, protein-protein interaction network, and survival analysis. A support vector machine (SVM) diagnostic model was constructed by a supervised classification algorithm. Univariate Cox analysis was performed to construct two prognostic signatures for overall survival and disease-free</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-05T11:57:13.9Z</modification><creation>2025-02-19T00:31:50.011Z</creation></dates><accession>S-EPMC9628086</accession><cross_references><pubmed>36319976</pubmed><doi>10.1186/s13062-022-00342-w</doi></cross_references></HashMap>